Skip to content

Clinical trials

Phase 3 Acute Coronary Syndrome trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Acute Coronary Syndrome Phase: Phase 3 Country / region: Australia Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20071
20082
20093
20104
20111
20141
20161
20181
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated3
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi3
AstraZeneca2
GlaxoSmithKline2
Amarin Pharma Inc.1
Anthera Pharmaceuticals1
Bristol-Myers Squibb1
CSL Behring1
Cogentus Pharmaceuticals1
DalCor Pharmaceuticals1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Acute Coronary Syndrome18
Myocardial Infarction6
Cardiovascular Diseases5
Coronary Artery Disease4
Heart Diseases4
Myocardial Ischemia3
Non-ST Elevated Myocardial Infarction3
ST Elevation Myocardial Infarction3
Stroke3
Angina, Unstable2

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.